DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« System Pharmacology: Using CellMiner and the NCI-60 Cancerous Cell Lines: William Reinhold, PhD

System Pharmacology in a Post-Genomic Era – The Simple Case of Dose-Response: Peter Sorger, PhD »

DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD

April 22, 2013 by 2012pharmaceutical

Reporter: Aviva Lev-Ari, PhD, RN

Systems Pharmacology – Pathways to Patient Response @ BioIT World, April 9-11, 2013, World Trade Center, Boston, MA

William Reinhold, PhD’s presentation at the conference is to be viewed at the link, below

http://www.chiresource.com/BIT-05-23/Presentations/NPC/Shen_James.pdf

Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits, Chemical Genetics, Computational Biology/Systems and Bioinformatics, Genome Biology | 1 Comment

One Response

on April 22, 2013 at 5:22 PM | Reply larryhbern

I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette

Loading...

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,459 other subscribers
Recent Posts
- Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
- The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
- Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
- Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
- Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
- Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
- Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
- Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: